IMTX
Immatics NV
NASDAQ · Healthcare · Biotechnology · DE
$8.62
−2.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.81x
- Price / sales
- 26.95x
- Price / cash flow
- -5.45x
Enterprise value
- Enterprise value
- $855.3M
- EV / sales
- 17.87x
- EV / EBITDA
- -3.84x
- EV / EBIT
- -3.29x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026